首页>International journal of hematology>Role of high-dose melphalan with autologous stem cell transplantation in multiple myeloma patients receiving botezomib-containing induction therapy
Role of high-dose melphalan with autologous stem cell transplantation in multiple myeloma patients receiving botezomib-containing induction therapy
作者单位：Department of Internal Medicine, Seoul St. Mary's Hospital, Catholic University of Korea College of[1]Department of Hematology, St. Vincent's Hospital, Catholic University of Korea, #505, Banpo-dong[2]Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, South Korea[3]
换一批
